Form 4 for TMO Thermo Fisher Scientific
Accepted 2026-09-01 16:10:37 ET · period of report 2026-08-28 · accession 0000097745-26-000161 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-01 16:10 | 2026-08-28 | TMO | Britt Lisa P. | SVP, Chief HR Off | F - Tax | $622.18 | -393.57 | 14.4K | -3% | -$244.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-08-28 | F | D | 87.03 | $622.18 | 14,697.12 | D | — | — | |
| 2 | Common | Common Stock | 2026-08-28 | F | D | 116.04 | $622.18 | 14,581.08 | D | — | — | |
| 3 | Common | Common Stock | 2026-08-28 | F | D | 105.40 | $622.18 | 14,475.67 | D | — | — | |
| 4 | Common | Common Stock | 2026-08-28 | F | D | 85.10 | $622.18 | 14,390.58 | D | — | — |